Compare ARVN & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | ASC |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.2M | 571.6M |
| IPO Year | 2018 | 2013 |
| Metric | ARVN | ASC |
|---|---|---|
| Price | $8.11 | $15.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 2 |
| Target Price | $15.05 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 685.8K | 681.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.06 | $9.90 |
| 52 Week High | $14.22 | $20.03 |
| Indicator | ARVN | ASC |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 44.68 |
| Support Level | N/A | $14.91 |
| Resistance Level | $8.90 | $15.98 |
| Average True Range (ATR) | 0.38 | 0.71 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 18.50 | 54.31 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.